Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Mitch Dowsett(Royal Marsden NHS Foundation Trust), J. Houghton(The Royal Free Hospital), Cecilie Riis Iden(The Royal Free Hospital), Janine Salter(Royal Marsden NHS Foundation Trust), J R Farndon(Bristol Royal Infirmary), Roger A’Hern(Institute of Cancer Research), R Sainsbury(The London College), Michael Baum(The Portland Hospital)
Annals of Oncology
February 24, 2006
10.1093/annonc/mdl016
Cited by 268Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis